Mitchell E. Levinson - Jun 9, 2022 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Chief Strategy Officer, Director
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/10/2022, 06:58 PM
Previous filing
Mar 24, 2023
Next filing
Oct 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Exercise of in-the-money or at-the-money derivative security +10.9K +41.16% 37.5K Jun 9, 2022 Direct F1, F2
transaction PLSE Common Stock Exercise of in-the-money or at-the-money derivative security +814 +24.51% 4.14K Jun 9, 2022 Spouse F1, F2
transaction PLSE Common Stock Exercise of in-the-money or at-the-money derivative security +143 +24.2% 734 Jun 9, 2022 Immediate family member F1, F2
transaction PLSE Common Stock Exercise of in-the-money or at-the-money derivative security +143 +24.2% 734 Jun 9, 2022 Immediate family member F1, F2
transaction PLSE Common Stock Exercise of in-the-money or at-the-money derivative security +143 +24.2% 734 Jun 9, 2022 Immediate family member F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Warrant (right to buy) Purchase +10.9K 10.9K Jun 9, 2022 Common Stock 10.9K $2.05 Direct F1, F2
transaction PLSE Warrant (right to buy) Purchase +814 814 Jun 9, 2022 Common Stock 814 $2.05 Spouse F1, F2
transaction PLSE Warrant (right to buy) Purchase +143 143 Jun 9, 2022 Common Stock 143 $2.05 Immediate family member F1, F2
transaction PLSE Warrant (right to buy) Purchase +143 143 Jun 9, 2022 Common Stock 143 $2.05 Immediate family member F1, F2
transaction PLSE Warrant (right to buy) Purchase +143 143 Jun 9, 2022 Common Stock 143 $2.05 Immediate family member F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC.
F2 Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05.